Human Immune System Mouse Core
人体免疫系统鼠标核心
基本信息
- 批准号:10238750
- 负责人:
- 金额:$ 16.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdultAnimal ModelAnimalsAntibodiesAutologousBLT miceBiopsyBloodBlood CellsBlood specimenCD4 Positive T LymphocytesCRISPR/Cas technologyCellsChlamydia trachomatisContainmentCorrelative StudyDataDevelopmentDoctor of PhilosophyEducationEngraftmentEvolutionFetal LiverFundingFutureGenerationsGrantHIVHIV InfectionsHIV/TBHealthcareHematopoieticHematopoietic stem cellsHumanImmuneImmune responseImmune systemImmunityImmunizationImmunoglobulinsImmunologic Deficiency SyndromesInfectionInvestigationKnock-in MouseLeukocytesLightLiverMacacaMacaca mulattaManuscriptsMediatingModelingMucous MembraneMusOperative Surgical ProceduresPathogenesisPatientsPersonsPhasePreparationPriceProceduresResearchResearch PersonnelSIVSamplingServicesSourceSystemT-LymphocyteTherapeuticThymic TissueTissue SampleTissuesUmbilical Cord BloodUnited States National Institutes of HealthUniversitiesVaccinesVirus Diseasesbioluminescence imagingcareerco-infectioncostexperimental studyhuman fetal thymushuman subjecthuman tissuehumanized mouseimplantationimprovedin vivoin vivo imaginginsightintravital microscopymembermicroscopic imagingmouse modelmultiphoton imagingnonhuman primatenucleaseperipheral bloodprogramsreconstitutionresponsesuccesstreatment effectvoucher
项目摘要
PROJECT SUMMARY/ABSTRACT
Human Immune System Mouse Core (Core H)
The Human Immune System Mouse Core (HISMC) will provide HU CFAR investigators with humanized mouse
models in which to study human immunodeficiency virus (HIV) infection. In addition, the HISMC will support
early career HU CFAR investigators to access these models through a Voucher program.
Despite extensive correlative studies of HIV-infected persons and ex vivo studies of peripheral blood cells and
tissue biopsies, fundamental questions about HIV pathogenesis and immunity remain unanswered. The ability
to study HIV through controlled perturbations of the immune system is limited in human subjects, and limited
access to human tissue samples makes the investigation of HIV replication and human immune responses to
HIV difficult in compartments other than the blood. Investigators have therefore turned to animal models, but
unfortunately an ideal animal model of HIV infection has remained elusive. Although simian immunodeficiency
virus (SIV) infection of rhesus macaques has provided many critically important insights into retroviral
pathogenesis and immunity, there are differences inherent in macaque immune responses to SIV and human
responses to HIV. Moreover, expenses associated with NHP studies limit access to this model. To address
these limitations, chimeric “humanized mice” with human immune cells have been generated. The HU CFAR
HISMC generates complementary humanized mouse models: human peripheral blood leukocytes (hu-PBL)
mice, hematopoietic stem cells (hu-HSC) mice and bone marrow-liver-thymus (BLT) mice. Studies supported
by the HISMC have demonstrated that these mice recapitulate multiple aspects of HIV infection in humans
such as the presence of an “eclipse phase” of infection following intravaginal challenge; similar depletion of
CD4+ T cell in peripheral blood and mucosal tissues following infection; and support advanced in vivo imaging
of HIV infection by multiphoton-intravital microscopy and bioluminescence imaging. They also offer a model to
study the effect of treatment, such as ART or antibodies, against HIV.
In the coming funding period, the HISMC will provide access to these models of humanized mice as a new
MGH/Partners Healthcare Core. As such, all costs involved in the generation of the mice and their
experimental manipulations are included in the price of the services. The CFAR support will be entirely
directed towards a voucher program to support access of early career HU CFAR investigators to these
services. These vouchers will cover costs related to humanized mice experiments and will be restricted to early
career HU CFAR investigators who have no grant funding for humanized mouse studies from other sources.
项目摘要/摘要
人免疫系统鼠标核心(核心H)
人类免疫系统鼠标核心(HISMC)将为HU CFAR研究人员提供人源化的小鼠
研究人类免疫缺陷病毒(HIV)感染的模型。此外,HISMC将支持
早期的HU CFAR调查人员通过凭证计划访问这些模型。
尽管对HIV感染者和外周血细胞和体内研究的广泛相关研究和
组织活检,有关HIV发病机理和免疫力的基本问题仍未得到解答。能力
通过免疫系统的受控扰动研究艾滋病毒是人类受试者的限制,并且有限
获取人体组织样本使HIV复制和人类免疫回报的投资
艾滋病毒在血液以外的腔室中难以进行。因此,调查人员转向动物模型,但是
不幸的是,理想的艾滋病毒感染动物模型仍然难以捉摸。虽然猿猴免疫缺陷
猕猴的病毒(SIV)感染为逆转录病毒提供了许多至关重要的见解
发病机理和免疫学,猕猴对SIV和人类的免疫反应存在差异
对艾滋病毒的反应。此外,与NHP研究相关的费用限制了对该模型的访问。解决
这些局限性,具有人类免疫细胞的嵌合“人性化小鼠”。 HU CFAR
HISMC生成完整的人源性小鼠模型:人类外周血白细胞(HU-PBL)
小鼠,造血干细胞(HU-HSC)小鼠和骨髓 - 肝硫肌(BLT)小鼠。支持研究
HISMC证明,这些小鼠概括了人类艾滋病毒感染的多个方面
例如,阴道爆发后感染的“日食”阶段的存在;类似的部署
感染后外周血和粘膜组织中的CD4+ T细胞;并支持高级体内成像
通过多光子内感染显微镜和生物发光成像,HIV感染的感染。他们还为
研究治疗的影响,例如ART或抗体,对HIV。
在即将到来的资金期间,HISMC将提供对这些人源化老鼠的访问权限
MGH/Partners Healthcare Core。因此,老鼠及其产生涉及的所有费用
实验操作包括在服务价格中。 CFAR支持将完全是
针对凭证计划,以支持早期职业生涯的访问hu CFAR调查人员参与这些
服务。这些优惠券将涵盖与人性化小鼠实验有关的成本,并将仅限于早期
职业生涯CFAR调查人员没有其他来源的人源化老鼠研究资金的资金。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alejandro Benjamin Balazs其他文献
Alejandro Benjamin Balazs的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alejandro Benjamin Balazs', 18)}}的其他基金
AAV Vectored Delivery of Broadly Neutralizing Antibodies with Optimal Innate Functionality Against HIV
AAV 载体递送具有针对 HIV 的最佳先天功能的广泛中和抗体
- 批准号:
10762553 - 财政年份:2023
- 资助金额:
$ 16.81万 - 项目类别:
Development of Vectored ImmunoProphylaxis as a strategy against HIV
开发载体免疫预防作为抗 HIV 策略
- 批准号:
8411105 - 财政年份:2014
- 资助金额:
$ 16.81万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10889325 - 财政年份:2023
- 资助金额:
$ 16.81万 - 项目类别:
Developing a Risk Index for Functional Decline in Middle-Aged and Older Adults with HIV
制定中老年艾滋病毒感染者功能衰退的风险指数
- 批准号:
10762280 - 财政年份:2023
- 资助金额:
$ 16.81万 - 项目类别: